SAB Biotherapeutics Provides Company Update for Q1 2022 Financial Results

Go back to SAB Biotherapeutics Provides Company Update for Q1 2022 Financial Results
(NASDAQ: SABS) Delayed: 3.81 +0.19 (5.25%)
Previous Close $3.62    52 Week High
Open $3.65    52 Week Low
Day High $3.81    P/E N/A 
Day Low $3.61    EPS
Volume 359,374       

(NASDAQ: SABSW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.04    52 Week Low
Day High $0.04    P/E N/A 
Day Low $0.03    EPS
Volume 50,324